QA: Lixte Biotechnology Holdings INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2024_Lixte_Biotechnology_Holdings_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001335105, Lixte Biotechnology Holdings INC

  xvar xval
0 AssetsCurrent 4,308,620
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 313,858
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,906,999
9 ResearchAndDevelopmentExpense 847,720
10 remainder_Expenses 2,478,185
11 remainder_Revenues 0
12 remainder_NetIncome 15,469
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,308,620
1 Liabilities 313,858
2 Expenses 5,232,904
3 Revenues 0
4 StockholdersEquity 3,994,762
5 NetIncome -5,217,435
6 ComprehensiveNetIncome -5,217,435
7 BaseVar 4,935,426
8 EconomicCapitalRatiobeforeLimitedLiability 1.51
9 EconomicCapitalRatio 2.69

Edgar->Model Mapping

Feature Distribution

Change over Time